/

/

Terran Biosciences Announces Licensing Deal with Pierre Fabre for Idazoxan; Completes Development...

Fri, Jun 2

.@TerranBio signs another deal with a legacy pharma company, this time obtaining an exclusive global license to late-stage CNS assets from Pierre Fabre. https://t.co/iPKrbXzV5z

0811

Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan; Terran completes key development milestones

Discover